Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer | Science Translational Medicine
Poziotinib Shows Promise in EGFR and HER2 Exon 20 Mutated
Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis
Key clinical trials in EGFR exon 20 insertion positive NSCLC | Download Table
Frontiers | Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib
Discovery of mobocertinib, a new irreversible tyrosine kinase inhibitor indicated for the treatment of non-small-cell lung cancer harboring EGFR exon 20 insertion mutations | SpringerLink
New therapeutic approaches to overcoming resistant EGFR exon 20 alterations - ScienceDirect
Altered conformational landscape and dimerization dependency underpins the activation of EGFR by <italic toggle='yes'
EXCLAIM-2 Clinical Study in NSCLC with EGFR exon 20 insertion mutations
Targeting EGFR Exon 20 Insertions in NSCLC: Current and Future Prospects - RMEI
EGFR Exon 20 Insertion Mutation and Lung Cancer | American Lung Association
New therapeutic approaches to overcoming resistant EGFR exon 20 alterations Alex M Lia (aml098@ucsd.edu), Amélie Boichardb (abo
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer | Signal Transduction and Targeted Therapy
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program - ScienceDirect
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer | Signal Transduction and Targeted Therapy
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer | BMC Cancer | Full Text
Cancer Research and Treatment
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations | PNAS
soria on Twitter: "Targeting #EGFR exon 20 insertion with TAK788 leads to ORR of 43% #AACR20 https://t.co/fYp5lEkShc" / Twitter
Inhibition of EGFR Signaling: All Mutations Are Not Created Equal | PLOS Medicine
Extensive functional evaluation of exon 20 insertion mutations of EGFR - ScienceDirect
Frontiers | Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases
EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib - Journal of Thoracic Oncology
Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis | SpringerLink
EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications - The Lancet Oncology
Cancers | Free Full-Text | EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer | Signal Transduction and Targeted Therapy
New therapeutic approaches to overcoming resistant EGFR exon 20 alterations Alex M Lia (aml098@ucsd.edu), Amélie Boichardb (abo
EGFR Exon20 | EXKIVITY® (mobocertinib)
